Toll Brothers Announces Entry Into Boise, Idaho Market With Acquisition of Coleman Homes
Nov 07, 2016 13:01 pm UTC| Business
HORSHAM, Pa., Nov. 07, 2016 -- Toll Brothers, Inc., (NYSE:TOL) (www.tollbrothers.com), the nation's leading builder of luxury homes, today announced its entry into the Boise, Idaho market through the acquisition of...
TubeMogul Debuts Attribution Solution
Nov 07, 2016 13:01 pm UTC| Business
EMERYVILLE, Calif., Nov. 07, 2016 -- Today, TubeMogul (NASDAQ:TUBE) announced the launch of Ad Swap to help marketers better isolate causality in advertising measurement. ...
Threshold Pharmaceuticals Reports Third Quarter Financial Results
Nov 07, 2016 13:01 pm UTC| Business
-- Planning to initiate a clinical trial of evofosfamide in combination with checkpoint inhibitors -- SOUTH SAN FRANCISCO, Calif., Nov. 07, 2016 -- Threshold Pharmaceuticals, Inc. (Nasdaq:THLD), a clinical-stage...
America First Multifamily Investors, L.P. Reports Third Quarter 2016 Earnings
Nov 07, 2016 13:01 pm UTC| Business
OMAHA, Nebraska, Nov. 07, 2016 -- On November 7, 2016, America First Multifamily Investors, L.P. (NASDAQ:ATAX) (the “Partnership”) reported the following operating results: For the quarter ended September 30, 2016 ...
Nov 07, 2016 13:01 pm UTC| Business
BERKELEY, Calif., Nov. 07, 2016 -- Aduro Biotech, Inc. (Nasdaq:ADRO) today highlighted an oral presentation given by the company’s chief scientific officer, Thomas Dubensky Jr., Ph.D., at the 4th European Society of...
Nov 07, 2016 13:01 pm UTC| Business
BERKELEY, Calif., Nov. 07, 2016 -- Aduro Biotech, Inc. (Nasdaq:ADRO) today highlighted an oral presentation given by the company’s chief scientific officer, Thomas Dubensky Jr., Ph.D., at the 4th European Society of...
Proteon Therapeutics Announces Third Quarter 2016 Financial Results
Nov 07, 2016 13:01 pm UTC| Business
WALTHAM, Mass., Nov. 07, 2016 -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular diseases, today...